This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
A new observational study suggests the position in which responders initially place the two defibrillator pads on the body may make a significant difference in returning spontaneous blood circulation after shock from a defibrillator.
Using light pulses as a model for electrical defibrillation, scientists developed a method to assess and modulate the heart function. The research team has thus paved the way for an efficient and direct treatment for cardiac arrhythmias. This may be an alternative for the strong and painful electrical shocks currently used.
Cardiac defibrillation ranks among the most important scientific developments and serves well as an iconic example of a procedure that changed medicine. This article highlights the first attempts at ventricular defibrillation and the development of the implantable defibrillator and the implantable transvenous cardioverter.
The MADIT trial1 conducted between 1991 and 1996 was the first trial testing primary prevention of mortality with an implantable cardioverter-defibrillator (ICD).
He only knows that first responders resuscitated his heart with a shock from a defibrillator, ultimately leading to his complete recovery and putting him among fewer than one in 10 people nationwide who survive cardiac arrest outside of a hospital. Joshua Lupton, M.D., has no memory of his own cardiac arrest in 2016.
Every year, those who receive implantable cardioverter/defibrillators (ICDs) are told to hand over the keys in varying degrees depending on the country or state in which they live. This not only impacts the life of the ‘grounded’ patient but also the friends and family around them.
(MedPage Today) -- BOSTON -- A leadless pacemaker reliably communicated with a subcutaneous implantable cardioverter-defibrillator (S-ICD) to deliver anti-tachycardia (ATP) and bradycardia pacing, the MODULAR ATP study showed. In terms of safety.
Specifically designed to prevent post-operative complications for devices such as pacemakers and defibrillators, EluPro incorporates powerful antibiotic therapy combined with advanced tissue engineering to create a BioEnvelope that over time regenerates into a protective pocket of the patient's own tissue.
Because athletes young and old can suffer cardiac arrest, some states have mandated the placement of automated external defibrillators (AEDs) in gyms, stadiums and other sports venues. But a new study finds the use of AEDs by bystanders for cardiac arrest at athletic sites didn't improve much after states enacted these laws.
Because athletes young and old can suffer cardiac arrest, some states have mandated the placement of automated external defibrillators (AEDs) in gyms, stadiums and other sports venues. But a new study finds the use of AEDs by bystanders for cardiac arrest at athletic sites didn't improve much after states enacted these laws.
Follow-up at a median of nearly 14 years showed a survival benefit for patients who received cardiac resynchronization with a defibrillator as compared with those who received a defibrillator alone.
Better risk stratification is needed to evaluate patients with non-ischemic cardiomyopathy (NICM) for prophylactic implantable cardioverter-defibrillators (ICD). Growing evidence suggests cardiac magnetic resonance imaging (CMR) may be useful in this regard.
15 minutes after EMS arrival, after at least 6 defibrillations, the patient achieved sustained ROSC. Written by Pendell Meyers A man in his 50s was found by his family in cardiac arrest of unknown duration. His family started CPR and called EMS, who arrived to find him in ventricular fibrillation. Further information is not available.
Patients with advanced cancer who also had cardiac defibrillators were more likely than those without these implants to receive aggressive end-of-life care, a team led by UT Southwestern Medical Center researchers found in a new study.
Biphasic waveforms were initially developed for use in implantable cardioverter defibrillators (ICD) and later adapted to external defibrillators. Defibrillators can sense the thoracic impedance and increase or decrease their internal resistance so that the selected level of energy is delivered to the subject.
Patients with AF were older and more symptomatic, had higher body mass index, more prevalent cardiovascular risk factors, a history of sustained ventricular tachycardia and implantable cardioverter-defibrillator, lower left ventricular ejection fraction (LVEF), larger left atria (LA) and more advanced LV diastolic dysfunction (pp<0.001 for all).
Receipt of a cardiac-resynchronization therapy-defibrillator (CRT-D) offers long term benefit for patients with heart failure, reduced ejection fraction, and a widened QRS complex, according to a study published in the Jan. 18 issue of the New England Journal of Medicine.
Is a novel modular pacing–defibrillator system, consisting of a leadless pacemaker in wireless communication with a subcutaneous implantable cardioverter–defibrillator (ICD), able to effectively and safely provide antitachycardia and bradycardia pacing?
(MedPage Today) -- Not all defibrillator pad positions may work equally well for patients with shockable out-of-hospital cardiac arrest. JAMA Network Open) Medical therapy for aortic stenosis? Early clinical data on evogliptin were disappointing.
The targeted Automated External Defibrillator (AED) program in the Sao Paulo Metro has yielded promising results in improving survival rates for individuals experiencing out-of-hospital cardiac arrest (OHCA) due to ventricular arrhythmias. Circulation, Volume 150, Issue Suppl_1 , Page ASu505-ASu505, November 12, 2024.
(MedPage Today) -- The Jewel patch-wearable cardioverter-defibrillator delivered successful shocks for protection from sudden cardiac arrest, and people were highly compliant to wearing the water-resistant device. Journal of the American College.
New multi-society Appropriate Use Criteria (AUC) published in JACC focus on cardiac implantable electronic devices (CIEDs), specifically implantable cardioverter-defibrillators (ICDs), cardiac resynchronization therapy (CRT), and pacing.
Implementing a community first responder (CFR) system, including earlier Basic Life Support and defibrillation, can enhance survival rates and neurological outcomes. Objective Out-of-hospital cardiac arrest (OHCA) is a major public health challenge across Europe, with a survival rate of only 8.5% to hospital discharge.
ABSTRACT Background and Aims The safety and efficacy of the subcutaneous implantable cardioverter-defibrillator (S-ICD) has been proven in various clinical trials. Eight patients preoperatively failed defibrillation testing with 65J and 80J. Postoperative defibrillation testing was successful in all patients.
While alternative strategies, such as leadless pacemakers and non-transvenous implantable cardioverter-defibrillators (ICD) have been introduced, they are not suitable for all patients.
Defibrillation leads remain the Achilles heel of implantable cardioverter-defibrillators. As patients with implantable cardioverter-defibrillators are living longer and battery longevity increases, more durable leads are needed. months and remains in clinical follow-up.
Objective The early use of automated external defibrillators (AEDs) improves outcomes in out-of-hospital cardiac arrest (OHCA). We investigated AED access across Great Britain (GB) according to socioeconomic deprivation.
BackgroundQuantitative ventricular fibrillation (VF) analysis has the potential to optimize defibrillation by predicting shock outcomes, but its performance remains unsatisfactory. Ten features and 10 parameters were obtained from the recorded VF and defibrillation waveforms. Journal of the American Heart Association, Ahead of Print.
Wireless implantable cardioverter-defibrillators (ICDs) eliminate the lead-related complications that come with a wired ICD, but they are unsuitable for patients with ventricular tachycardia, when the heart beats too quickly, or bradycardia, when the resting heart rate is seen as low.
The PRAETORIAN score is developed as an alternative for defibrillation testing(DFT) post subcutaneous implantable cardioverter-defibrillator (S-ICD) implantation, and assess three aspects of implant position on a bidirectional chest X-ray.
The SMART Pass algorithm for subcutaneous implantable cardioverter-defibrillator prevents inappropriate shocks due to oversensing. The mechanisms and significance of SMART Pass deactivation remain unclear.
AimsThis retrospective cohort study aimed to investigate the efficacy of dual-chamber left Bundle branch pacing (LBBP) as an alternative therapy for heart failure patients with complete left bundle branch block (CLBBB) and indications for defibrillator with cardiac resynchronization therapy (CRT-D).Methods34 to 61.06.0% (P<0.001).
BackgroundIn the electrophysiologic (EP) lab, technical support for implantable cardioverter/defibrillators (ICD) and cardiac resynchronization therapy (CRT-D) procedures is often limited by the availability and costs of field clinical specialist (FCS) bioengineers.MethodsThis study explores the viability of using remote support through an internet-based (..)
Premarket clinical trials have shown the extravascular implantable cardioverter-defibrillator (EV-ICD) system to provide effective therapy with a low complication rate, but its performance in the real world is unknown.
Such innovation in painless defibrillation and preventing arrhythmia could revolutionize cardiac rhythm management. The scientific advance is significant considering pain management is highly relevant to overall wellness for patients with heart, lung, and blood diseases.
Learning objectives Understand which patients with heart failure should be considered for a primary prevention implantable cardioverter defibrillator (ICD). Introduction Four decades ago, Mirowski et al reported on the first three humans treated with an automatic implantable defibrillator.
Normally-functioning implantable cardioverter-defibrillators (ICDs) with intact lead systems occasionally fail to deliver therapy for ventricular tachycardia/ fibrillation (VT/VF) or deliver it only after clinically-significant delays (“failure-to-treat”).
Due to differences in body habitus and breast anatomy, female patients may suffer from higher rates of complications after subcutaneous implantable cardioverter defibrillator (S-ICD) implantation as compared to male patients.
Non-transvenous implantable cardioverter-defibrillator (ICD) therapy offers life-saving therapy without using intravascular leads. Recommended ICD generator placement is in the left mid- axilla between the latissimus dorsi muscle (LDM) and serratus anterior muscle (SAM) to optimize the defibrillation threshold and cosmetic outcomes.
Implantable cardioverter-defibrillator (ICD) battery longevity impacts the need for generator replacement and may be an important distinguishing characteristic between manufacturers.
The 2017 HRS expert consensus paper on lead management and extraction did not express a preference for either extracting or abandoning pacing or defibrillator leads that are dysfunctional or superfluous after an upgrade (further referred to as redundant leads) 1.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content